Dual antiplatelet therapy after carotid artery stenting for high bleeding risk
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests if taking two blood thinners (dual antiplatelet therapy) after a carotid artery stenting procedure is safe and effective for patients who have a higher risk of bleeding. It focuses on people with significant blockages in the neck arteries who are also at increased risk for serious bleeding or brain bleeds.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 19 years or older.
- You have a blocked carotid artery (neck artery) that is more than 50% blocked and you have had symptoms, or more than 70% blocked without symptoms.
- You are scheduled for or have already had a carotid artery stenting procedure.
- You have a high risk of serious bleeding (like stomach or brain bleeds) as defined by the study, including conditions like being 75 or older, having low platelets, kidney or liver disease, or a history of certain bleeds.
- You are not currently taking blood thinners (like warfarin) or other antiplatelet drugs besides aspirin and clopidogrel.
- You are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at whether taking two blood thinners (aspirin plus clopidogrel or ticagrelor) after a heart stent procedure is safe and effective for people who already have low platelet counts. It may help doctors decide the best treatment for you if you have both low platelets and a stent.
This trial tests a shorter course of dual antiplatelet therapy (aspirin plus ticagrelor) after stent placement, switching early to just ticagrelor alone. It aims to see if this approach can safely reduce bleeding risks while still protecting against heart problems in people with stable coronary artery disease.
This trial tests an algorithm (computer-guided plan) to choose the best “dual antiplatelet therapy” (two blood-thinning medicines) after a coronary stent. It aims to improve outcomes after the procedure while reducing avoidable problems from the medicines.
This trial tests whether taking just one blood thinner (clopidogrel) is as safe and effective as taking two (clopidogrel plus aspirin) for older adults or people at high bleeding risk who have had a drug-coated balloon procedure to open blocked heart arteries.
This trial tests if a shorter, lower dose of two blood thinners is safe and effective for patients with a recent heart attack or unstable angina who are at high risk for bleeding. It uses a special stent that might allow for less medication.
This trial studies ways to reduce bleeding in people after a stent procedure (PCI) who have been taking two anti-platelet medicines (aspirin plus prasugrel or ticagrelor) for a set amount of time. It may help find a safer plan for preventing blood clots while lowering bleeding risk.
Hear when a new Carotid Artery Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.